BrightStar announces two new investments, releases 2017 annual report
MILWAUKEE, March 29, 2018 – BrightStar Wisconsin Foundation Inc. today announced that it has committed $100,000 to Cytometix Inc., d.b.a. Cmxtwenty, and $50,000 to GenoPalate Inc. Both companies are based in the Milwaukee area and have ties to the Medical College of Wisconsin. During the past decade, Cmxtwenty developed a therapeutic pharmaceutical that is modeled […]